Article Text

Download PDFPDF

P080 Investigating the effects of accelerated partner therapy on chlamydia transmission in britain: a mathematical modelling study
  1. Christian Althaus1,
  2. Catherine Mercer2,
  3. Jackie Cassell3,
  4. Claudia Estcourt4,
  5. Nicola Low5
  1. 1University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland
  2. 2University College London, Institute for Global Health, London, UK
  3. 3Brighton and Sussex Medical School, Primary Care and Public Health, Brighton and Hove, UK
  4. 4Glasgow Caledonian University, School of Health and Life Sciences, Glasgow, UK
  5. 5University of Bern, Institute of Social and Preventive Medicine (ISPM), Bern, Switzerland


Background Understanding the effects of partner notification (PN) on chlamydia transmission is critical for implementing optimal control strategies. Accelerated partner therapy (APT) aims to reduce the time to partner treatment and increase the proportion of partners treated. As part of LUSTRUM, a PN trial in the UK, our objective was to study the effects of APT interventions on partner treatment and chlamydia transmission using a mathematical model.

Methods We developed a deterministic, population-based chlamydia transmission model including the process of PN. We considered a heterosexual population aged 16–34 years and calibrated the model to sexual behaviour and chlamydia prevalence data reported by 3,671 participants in Britain’s third National Survey of Sexual Attitudes and Lifestyles (Natsal-3, 2010–2012) using Approximate Bayesian Computation (ABC). We investigated the potential effects of APT on chlamydia transmission by reducing the time to partner treatment and increasing the proportion of treated partners compared to standard PN.

Results The median prevalence of chlamydia in the model was 1.8% (95% credible interval (CrI): 1.6%-2.6%) in women and 1.7% (95% CrI: 1.1%-2.1%) in men. Overall, chlamydia-positivity in partners of index cases was 55% (95% CrI: 31%-79%), and higher in partners of symptomatic index cases (76%) than asymptomatic index cases (33%). Reducing the time to partner treatment without achieving higher proportions of partners treated had only small effects on reducing chlamydia prevalence. In contrast, the model predicts that a potential increase in the proportion of partners treated from current levels in the UK (36%, 95% CrI: 13%-96%) by 25% would reduce chlamydia prevalence by 14% (95% CrI: 3%-40%) in women and by 14% (95% CrI: 3%-39%) in men within 5 years.

Conclusion Our results suggest that APT, through an increase in the proportion of partners treated, would be an effective method to reduce ongoing chlamydia transmission in the UK.

Disclosure No significant relationships.

  • expedited partner therapy
  • chlamydia
  • United Kingdom

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.